Published in Nucleic Acids Res on November 29, 2011
Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep (2013) 1.36
Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet (2015) 1.17
Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol (2014) 1.03
Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein. Antimicrob Agents Chemother (2013) 0.93
RIG-I ATPase activity and discrimination of self-RNA versus non-self-RNA. MBio (2015) 0.91
Nucleic acid aptamers: research tools in disease diagnostics and therapeutics. Biomed Res Int (2014) 0.88
Rig-I regulates NF-κB activity through binding to Nf-κb1 3'-UTR mRNA. Proc Natl Acad Sci U S A (2013) 0.87
Screening of aptamers on microfluidic systems for clinical applications. Sensors (Basel) (2012) 0.84
Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction. J Virol (2015) 0.84
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. J Virol (2015) 0.84
Aptamers in diagnostics and treatment of viral infections. Viruses (2015) 0.80
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses. Pharmaceuticals (Basel) (2016) 0.79
Inhibition of hepatitis C virus production by aptamers against the core protein. J Virol (2013) 0.79
Antiviral Effects of Novel Herbal Medicine KIOM-C, on Diverse Viruses. PLoS One (2015) 0.78
2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors. Nucleic Acid Ther (2016) 0.78
Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein. PLoS One (2014) 0.77
Model-based simulation and prediction of an antiviral strategy against influenza A infection. PLoS One (2013) 0.76
Inhibition of Influenza Virus Replication by DNA Aptamers Targeting a Cellular Component of Translation Initiation. Mol Ther Nucleic Acids (2016) 0.75
Oligonucleotide aptamers: potential novel molecules against viral hepatitis. Res Pharm Sci (2017) 0.75
Manipulating the in vivo immune response by targeted gene knockdown. Curr Opin Immunol (2015) 0.75
Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform. Sci Rep (2016) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Pathogen recognition and innate immunity. Cell (2006) 44.14
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00
5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol (2003) 15.67
Rapid evolution of RNA genomes. Science (1982) 14.76
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 9.00
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature (2008) 6.25
Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature (2005) 6.21
Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci (2008) 5.95
Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell (2010) 5.83
Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A (2006) 5.70
Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity (2009) 5.70
Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol (2006) 5.48
Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell (2008) 5.20
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev (2009) 4.41
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med (2007) 4.39
Aptamers: an emerging class of therapeutics. Annu Rev Med (2005) 4.15
Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science (2009) 4.00
Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol (2004) 3.85
Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell (2006) 3.83
A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol (2006) 3.46
Aptamers come of age - at last. Nat Rev Microbiol (2006) 3.33
Influenza and the challenge for immunology. Nat Immunol (2006) 3.24
Challenges and successes in developing new therapies for hepatitis C. Nature (2005) 3.22
5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A (2009) 3.05
Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol (2006) 2.76
Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem (2005) 2.70
Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol (2009) 2.37
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol (2009) 2.10
A SELEX primer. Methods Enzymol (1996) 1.90
Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov (2002) 1.75
The Immunobiology of SARS*. Annu Rev Immunol (2007) 1.61
Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther (2001) 1.49
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A (2005) 1.48
Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol (1990) 1.34
Hepatitis C virus infection: when silence is deception. Trends Immunol (2003) 1.29
Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci U S A (1995) 1.18
Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J Gen Virol (2008) 1.05
'Toll' gates for future immunotherapy. Curr Pharm Des (2006) 1.03
Characterization of the innate immune signalling pathways in hepatocyte cell lines. J Viral Hepat (2008) 1.03
Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. Eur J Biochem (2000) 1.03
Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology (1997) 0.94
The pharmacology of endosomal TLR agonists in viral disease. Biochem Soc Trans (2007) 0.94
From the analyst's couch: TLR-targeted therapeutics. Nat Rev Drug Discov (2005) 0.86
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J Virol (1999) 0.85
Active caspase-1-mediated secretion of retinoic acid inducible gene-I. J Immunol (2008) 0.84
Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol (2006) 9.17
The Drosophila amidase PGRP-LB modulates the immune response to bacterial infection. Immunity (2006) 3.51
PGRP-LC and PGRP-LE have essential yet distinct functions in the drosophila immune response to monomeric DAP-type peptidoglycan. Nat Immunol (2006) 2.12
The architecture of the multisubunit TRAPP I complex suggests a model for vesicle tethering. Cell (2006) 2.10
Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68. PLoS Pathog (2008) 2.09
Coordination of multiple dual oxidase-regulatory pathways in responses to commensal and infectious microbes in drosophila gut. Nat Immunol (2009) 2.06
Structural and functional insights into the B30.2/SPRY domain. EMBO J (2006) 1.82
Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol (2007) 1.75
Crystal structure of peptidoglycan recognition protein LB from Drosophila melanogaster. Nat Immunol (2003) 1.73
Structural basis for preferential recognition of diaminopimelic acid-type peptidoglycan by a subset of peptidoglycan recognition proteins. J Biol Chem (2006) 1.69
Crystal structure of a clip-domain serine protease and functional roles of the clip domains. EMBO J (2005) 1.58
Structural studies of a bacterial condensin complex reveal ATP-dependent disruption of intersubunit interactions. Cell (2009) 1.58
Structural basis for protein recognition by B30.2/SPRY domains. Mol Cell (2006) 1.54
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res (2010) 1.48
Clustering of peptidoglycan recognition protein-SA is required for sensing lysine-type peptidoglycan in insects. Proc Natl Acad Sci U S A (2007) 1.44
The ABC transporter AtABCB14 is a malate importer and modulates stomatal response to CO2. Nat Cell Biol (2008) 1.42
The TRAPP complex: insights into its architecture and function. Traffic (2008) 1.40
Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. Bioorg Med Chem Lett (2008) 1.36
UVRAG: a new player in autophagy and tumor cell growth. Autophagy (2007) 1.29
Structural insights into the dual nucleotide exchange and GDI displacement activity of SidM/DrrA. EMBO J (2009) 1.26
Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation. Proc Natl Acad Sci U S A (2002) 1.23
Crystal structure of SEDL and its implications for a genetic disease spondyloepiphyseal dysplasia tarda. J Biol Chem (2002) 1.23
Structure of malonamidase E2 reveals a novel Ser-cisSer-Lys catalytic triad in a new serine hydrolase fold that is prevalent in nature. EMBO J (2002) 1.20
Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci (2009) 1.20
Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology (2003) 1.19
DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep (2012) 1.18
An asymmetric SMC-kleisin bridge in prokaryotic condensin. Nat Struct Mol Biol (2013) 1.17
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe (2012) 1.16
Biological characterization of EDC-crosslinked collagen-hyaluronic acid matrix in dermal tissue restoration. Biomaterials (2003) 1.14
Highly efficient protein expression and purification using bacterial hemoglobin fusion vector. Plasmid (2005) 1.12
Crystal structure of bet3 reveals a novel mechanism for Golgi localization of tethering factor TRAPP. Nat Struct Mol Biol (2004) 1.11
Cyclomaltodextrinase, neopullulanase, and maltogenic amylase are nearly indistinguishable from each other. J Biol Chem (2002) 1.06
An insight into the mechanistic role of Beclin 1 and its inhibition by prosurvival Bcl-2 family proteins. Autophagy (2008) 1.06
Plunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomy. J Biol Chem (2002) 1.05
Peptide conjugates of oligonucleotides: synthesis and applications. Chem Rev (2006) 1.03
Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci (2004) 1.02
Heterocyclic nucleoside analogues: design and synthesis of antiviral, modified nucleosides containing isoxazole heterocycles. Bioorg Med Chem Lett (2002) 1.01
VipD of Legionella pneumophila targets activated Rab5 and Rab22 to interfere with endosomal trafficking in macrophages. PLoS Pathog (2012) 1.00
Identification of alpha-enolase as an autoantigen associated with severe asthma. J Allergy Clin Immunol (2006) 1.00
Kaposi's sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation. J Virol (2013) 0.99
Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell (2004) 0.98
Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol (2010) 0.98
Crystal structure of the Gtr1p(GTP)-Gtr2p(GDP) protein complex reveals large structural rearrangements triggered by GTP-to-GDP conversion. J Biol Chem (2012) 0.97
Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci (2003) 0.97
Macromolecular assembly of Helicobacter pylori urease investigated by mass spectrometry. J Mass Spectrom (2003) 0.96
Regulation of Drosophila vasa in vivo through paralogous cullin-RING E3 ligase specificity receptors. Mol Cell Biol (2010) 0.95
Structural double-mutant cycle analysis of a hydrogen bond network in ketosteroid isomerase from Pseudomonas putida biotype B. Biochem J (2004) 0.95
Quencher-free molecular beacons: a new strategy in fluorescence based nucleic acid analysis. Chem Soc Rev (2008) 0.94
hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions. J Biol Chem (2007) 0.94
C5-Modified nucleosides exhibiting anticancer activity. Bioorg Med Chem Lett (2009) 0.94
Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Oncogene (2002) 0.93
Identification, structural, and biochemical characterization of a group of large Csn2 proteins involved in CRISPR-mediated bacterial immunity. Proteins (2012) 0.93
Generalized vitiligo after allogeneic bone marrow transplantation. Acta Derm Venereol (2005) 0.93
Characterization of a novel Ser-cisSer-Lys catalytic triad in comparison with the classical Ser-His-Asp triad. J Biol Chem (2003) 0.91
Crystal structure of the MukB hinge domain with coiled-coil stretches and its functional implications. Proteins (2010) 0.91
Crystal structure and nucleic acid-binding activity of the CRISPR-associated protein Csx1 of Pyrococcus furiosus. Proteins (2012) 0.90
Biochemical and crystallographic studies reveal a specific interaction between TRAPP subunits Trs33p and Bet3p. Traffic (2005) 0.90
A genome-wide analysis of the acute-phase response and its regulation by Stat3beta. Ann N Y Acad Sci (2003) 0.90
Leukemia inhibitory factor promotes olfactory sensory neuronal survival via phosphoinositide 3-kinase pathway activation and Bcl-2. J Neurosci Res (2009) 0.89
Origin of the different pH activity profile in two homologous ketosteroid isomerases. J Biol Chem (2003) 0.88
Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease. J Rheumatol (2010) 0.88
Experimental phasing using zinc anomalous scattering. Acta Crystallogr D Biol Crystallogr (2012) 0.86
Crystal structures of RbsD leading to the identification of cytoplasmic sugar-binding proteins with a novel folding architecture. J Biol Chem (2003) 0.85
Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes. Acta Crystallogr D Biol Crystallogr (2013) 0.85
Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices. Nucleic Acids Res (2011) 0.85
Quencher-free, end-stacking oligonucleotides for probing single-base mismatches in DNA. Org Lett (2005) 0.85
IL-1β-specific recruitment of GCN5 histone acetyltransferase induces the release of PAF1 from chromatin for the de-repression of inflammatory response genes. Nucleic Acids Res (2013) 0.84
Active caspase-1-mediated secretion of retinoic acid inducible gene-I. J Immunol (2008) 0.84
Biphasic RLR-IFN-β response controls the balance between antiviral immunity and cell damage. J Immunol (2013) 0.84
Label-free electrochemical detection of the p53 core domain protein on its antibody immobilized electrode. Anal Chem (2009) 0.83
Prediction and experimental validation of novel STAT3 target genes in human cancer cells. PLoS One (2009) 0.83
Novel phosphoramidite building blocks in synthesis and applications toward modified oligonucleotides. Curr Med Chem (2003) 0.83
A highly discriminating quencher-free molecular beacon for probing DNA. J Am Chem Soc (2004) 0.83
Probing the B-to-Z-DNA duplex transition using terminally stacking ethynyl pyrene-modified adenosine and uridine bases. Chem Commun (Camb) (2005) 0.82
Phosphoinositides differentially regulate protrudin localization through the FYVE domain. J Biol Chem (2012) 0.82
Weight of polyethylene wear particles is similar in TKAs with oxidized zirconium and cobalt-chrome prostheses. Clin Orthop Relat Res (2009) 0.82
Focal localization of MukBEF condensin on the chromosome requires the flexible linker region of MukF. FEBS J (2009) 0.82
Synthesis and enzyme inhibitory activities of novel peptide isosteres. Curr Med Chem (2002) 0.81
Clinical features of patients with Behçet's disease and epididymitis. J Urol (2003) 0.81
Probing the stable G-quadruplex transition using quencher-free end-stacking ethynyl pyrene-adenosine. Chem Commun (Camb) (2007) 0.81
Crystal structure of DeSI-1, a novel deSUMOylase belonging to a putative isopeptidase superfamily. Proteins (2012) 0.81
An insulin-sensing sugar-based fluorescent hydrogel. Chem Commun (Camb) (2006) 0.80
Crystallization and preliminary X-ray crystallographic analysis of malonamidase E2, an amidase signature family member. Acta Crystallogr D Biol Crystallogr (2002) 0.80
Label-free detection of antibody-antigen interactions on (R)-lipo-diaza-18-crown-6 self-assembled monolayer modified gold electrodes. Anal Chem (2008) 0.80
Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages. Bioconjug Chem (2012) 0.79
Pyrene-labeled deoxyuridine and deoxyadenosine: fluorescent discriminating phenomena in their duplex and hairpin oligonucleotides. Nucleic Acids Symp Ser (Oxf) (2005) 0.79
Biotin-amino acid conjugates: an approach toward self-assembled hydrogelation. Org Lett (2005) 0.79
Modulation of substrate preference of thermus maltogenic amylase by mutation of the residues at the interface of a dimer. Biosci Biotechnol Biochem (2007) 0.79
Association of novel domain in active site of archaic hyperthermophilic maltogenic amylase from Staphylothermus marinus. J Biol Chem (2012) 0.79
Arg-158 is critical in both binding the substrate and stabilizing the transition-state oxyanion for the enzymatic reaction of malonamidase E2. J Biol Chem (2006) 0.79